Literature DB >> 4330544

[The pathogenesis of myasthenia gravis as an immunological problem].

J R Kalden.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4330544     DOI: 10.1007/bf01486122

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


× No keyword cloud information.
  124 in total

1.  Myasthenia gravis.

Authors:  A J STRAUSS
Journal:  Br Med J       Date:  1963-01-05

2.  Myasthenia gravis occurring in association with a malignant thymic tumour.

Authors:  P ELLMAN; D C HODGSON
Journal:  Br Med J       Date:  1958-03-15

3.  Studies in myasthenia gravis: demonstration of presence of immunofluorescence in serums correlated with clinical findings.

Authors:  L B Weiner; K E Osserman
Journal:  Ann N Y Acad Sci       Date:  1966-01-26       Impact factor: 5.691

4.  Further studies on the specificity of presumed immune associations of myasthenia gravis and consideration of possible pathogenic implications.

Authors:  A J Strauss; C W Smith; G W Cage; H W van der Geld; D E McFarlin; M Barlow
Journal:  Ann N Y Acad Sci       Date:  1966-01-26       Impact factor: 5.691

5.  Muscle antibodies in myasthenic mothers and their babies.

Authors:  H J Oosterhuis; T E Feltkamp; H R van der Geld
Journal:  Lancet       Date:  1966-12-03       Impact factor: 79.321

6.  Antibodies against the various types of skeletal muscle fibres.

Authors:  T E Feltkamp; T M Feltkamp-Vroom
Journal:  Immunology       Date:  1965-09       Impact factor: 7.397

7.  Striated muscle in human thymus.

Authors:  K Henry
Journal:  Lancet       Date:  1968-03-23       Impact factor: 79.321

8.  Autoantibodies and myasthenia gravis, with special reference to muscle ribonucleoprotein.

Authors:  T Namba; D Grob
Journal:  Ann N Y Acad Sci       Date:  1966-01-26       Impact factor: 5.691

9.  Presynaptic mechanisms in myasthenia gravis.

Authors:  J E Desmedt
Journal:  Ann N Y Acad Sci       Date:  1966-01-26       Impact factor: 5.691

10.  An assessment of changes in the complement level of myasthenic sera.

Authors:  O J Plescia; J M Segovia; A Strampp
Journal:  Ann N Y Acad Sci       Date:  1966-01-26       Impact factor: 5.691

View more
  2 in total

1.  [Thymectomy in the management of myasthenia].

Authors:  F Balzereit; V Bay; H Otto; P Rittmeyer; C Sobirey
Journal:  Z Neurol       Date:  1972

2.  [Heterogeneity of acetylcholine receptor antibodies in patients with myasthenia gravis].

Authors:  I Kalies; F Heinz; W P Kaschka; K F Druschky; J R Kalden
Journal:  Klin Wochenschr       Date:  1984-04-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.